Ramdan Hours:
Sun - Thu
9.30 AM - 2.30 PM
Iftar in --:--:--
🌙 Maghrib: --:--

Preparation and evaluation of topical nanoformulations for treatment of melasma / (Record no. 13049)

MARC details
000 -LEADER
fixed length control field 05681nam a22003497i 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220704s2022 ua a|||f bm|| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-NcFUE
Transcribing agency EG-NcFUE
Modifying agency EG-NcFUE
Description conventions rda
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
Language code of summary or abstract/overprinted title or subtitle ara
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 23
Classification number 617.47
Item number S.S.P
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Saleh, Shymaa Hatem Abd El-Azeem
Relator term author.
245 10 - TITLE STATEMENT
Title Preparation and evaluation of topical nanoformulations for treatment of melasma /
Statement of responsibility, etc by Shymaa Hatem Abd El-Azeem Saleh ; Supervisors : Prof. Dr. Seham Abd El-Khalek ElKheshen Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Prof.Dr. Amany Osama Kamel Professor of Pharmaceutics & Industrial Pharmacy and Dean of Faculty of Pharmacy, Ain shams University, Assoc. Prof. Dr. Maha Nasr Sayed Associate Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain shams University, Dr. Reham Samir Atia Lecturer of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain shams University, Dr. Nada Mohamed El Hoffy Lecturer of Pharmaceutics and Pharmaceutical technology, Faculty of Pharmacy, Future University in Egypt.
246 35 - VARYING FORM OF TITLE
Title proper/short title تحضير و تقييم مستحضرات موضعية نانوية لعلاج الكلف
264 #0 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc 2022
300 ## - PHYSICAL DESCRIPTION
Extent 444 pages :
Other physical details illustrations ;
Dimensions 24 cm
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
Content type code txt
337 ## - MEDIA TYPE
Source rdamedia
Media type term unmediated
Media type code n
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term volume
Carrier type code nc
500 ## - GENERAL NOTE
General note Supervisors : Prof. Dr. Seham Abd El-Khalek ElKheshen Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Prof.Dr. Amany Osama Kamel Professor of Pharmaceutics & Industrial Pharmacy and Dean of Faculty of Pharmacy, Ain shams University, Assoc. Prof. Dr. Maha Nasr Sayed Associate Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain shams University, Dr. Reham Samir Atia Lecturer of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain shams University, Dr. Nada Mohamed El Hoffy Lecturer of Pharmaceutics and Pharmaceutical technology, Faculty of Pharmacy, Future University in Egypt.
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.)--Ain shams University, Faculty of pharmacy, pharmaceutical & industrial pharmacy Department, 2022.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references (pages 364- 442).
520 3# - SUMMARY, ETC.
Summary, etc Effect of formulation factors on the EE% of the obtained CSNPs<br/>The EE% is one of the most important physicochemical characteristics of nanocarriers. High encapsulation efficiency ensures more bioavailability and high concentration of targeted drug, which helps in the reduction of the required dose for therapy and thereby decreases the dose-related systemic side effects (Rangasamy et al., 2008). As shown in Table 19, the percent EE% of α-arbutin in CSNPs varied from 63.65% to 88.45%. <br/> ANOVA results revealed the significance for the proposed model (P<0.0001). The model showed high values of R^2 (0.9210), adjusted R^2 (0.8469), and moderate predicted R^2 (0.6839), with high adequate-precision value (8.742). Similarly, the Box-Cox Plot for power transformations (Fig. 11) showed that the current lambda lied within the 95% confidence interval suggesting no recommended transformation. <br/> Assessment of main effects and interactions by the experimental design study showed that the EE% of the prepared α-arbutin-CSNPs was only affected by the chitosan concentration (XA). The estimated contribution of each term in the model showed the great influence of the term X_A (concentration of chitosan) when compared to the other three factors, as reported in Table 20. Similarly, the interaction factors did not play an important role as previously observed in the P.S and PDI analysis models. The linear regression model as obtained from the full factorial study is represented by Eq.15:<br/>Y = 76.23–10.15X_A + 0.24X_B + 0.50X_C–1.06X_D- 0.76X_A X_B+ 0.71X_A X_C- 0.33X_A X_D-0.68X_B X_C+0.19X_B X_D – 2.04X_C X_D+0.44X_A X_B X_C - 0.29X_A X_B X_D+0.14X_A X_C X_D+0.46X_B X_C X_D+ 0.44X_A X_B X_C X_D. (Eq.15)<br/> <br/> The effect of the concentration of chitosan (XA) on the EE% of α-arbutin within CSNPs was confirmed by its statistical significant effect (P < 0.0001) as shown in Table 21 compared to the other four independent variables, in which by increasing the chitosan concentration from 0.15 to 0.30 % w/v, the EE% of the prepared CSNPs decreased significantly (P<0.05). This might be caused by the dramatic increase in viscosity and gel formation with increased chitosan concentration, which hindered the encapsulation of α-arbutin, thereby decreasing the encapsulation efficiency as previously discussed in the preliminary section. This is in accordance with the findings of Gulati et al., 2013 who studied the formulation of sumatriptan succinate into CSNPs, as well as Shah et al., 2009 who investigated the incorporation of venlafaxine hydrochloride into the CSNPs.<br/><br/><br/> Three-dimensional surface plots are shown in Figures 12(a-d) to determine the influence of the independent factors on the EE% of α-arbutin-loaded CSNPs and clarify the relationship between factors X_A and X_B at both high and low levels of factors X_C and X_D.
546 ## - LANGUAGE NOTE
Language note Text in English, Abstract in English and Arabic
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Topical Treatment.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Topical Treatment of Melasma.
700 1# - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 33945
Personal name ElKheshen, Seham Abd El-Khalek
Relator term supervisor.
700 1# - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 33946
Personal name Kamel, Amany Osama
Relator term supervisor.
700 1# - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 33947
Personal name Sayed, Maha Nasr
Relator term supervisor.
700 1# - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 33948
Personal name El Hoffy, Nada Mohamed
Relator term supervisor.
700 1# - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 33949
Personal name Atia, Reham Samir
Relator term supervisor.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://repository.fue.edu.eg/xmlui/handle/123456789/6061
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Item type Thesis
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Method of acquisition Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
  Dewey Decimal Classification     Pharmacy ( Pharmaceutical Technology ) Main library Main library C5 PHD 04/07/2022 Donation 2022   617.47 S.S.P 00016667 20/02/2025 04/07/2022 Thesis